Skip to main content

This website is intended exclusively for healthcare professionals residing and/or working in the KSA.

  1. Article
  2. Source: Campus Sanofi
  3. Sep 18, 2026
5 min

The Effect of Dupilumab on the Atopic March and Risk of Nonatopic Comorbidities in Pediatric Patients with AD

Author: Sanofi

Sanofi Editorial team

MAT-BH-2600500  

Related

Privacy Notice Update | We have updated our Privacy Notice for Healthcare Professionals to improve your experience collaborating with us, maintain high standards of privacy and ultimately strengthen the trust you place in us. Key improvements include enhanced clarity on why and how Sanofi processes your personal data.
SitemapLegal noticePrivacy PolicyCookie PolicyContactAccessibility statement

© Sanofi 2004-2026 - All rights reserved

MAT-SA-2100978/V10/APR2026

Privacy Notice Update | We have updated our Privacy Notice for Healthcare Professionals to improve your experience collaborating with us, maintain high standards of privacy and ultimately strengthen the trust you place in us. Key improvements include enhanced clarity on why and how Sanofi processes your personal data.
SitemapLegal noticePrivacy PolicyCookie PolicyContactAccessibility statement

© Sanofi 2004-2026 - All rights reserved

MAT-SA-2100978/V10/APR2026